H

Hamideh Parhiz

Translational Therapeutics (United States)

ORCID: 0000-0002-2880-2836

62 papers and 6.1k citations.

PubIndex Score99Top 1% · mid-careerHow it's scored

🌱#2 Emerging Leader in Integrated Circuits and Semiconductor Failure Analysis 🌱#4 Emerging Leader in Advancements in Semiconductor Devices and Circuit Design

62Publications

6.1kTotal Citations

#2in Integrated Circuits and Semiconductor Failure Analysis

First publication: 2012First senior author: 2021

Top publicationsby citations

CAR T Cells Produced in vivo to Treat Cardiac Injury

Joel G. Rurik, Jonathan A. Epstein, István Tombácz et al.|HAL (Le Centre pour la Communication Scientifique Directe)|2023

Cited by 940

Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs

István Tombácz, Hamideh Parhiz, Dorottya Laczkó et al.|Molecular Therapy|2021

Cited by 272

In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism

Margaret M. Billingsley, Michael J. Mitchell, Xuexiang Han et al.|Small|2023

Cited by 216

Targeting lipid nanoparticles to the blood-brain barrier to ameliorate acute ischemic stroke

Jia Nong, Oscar A. Marcos‐Contreras, Patrick M. Glassman et al.|Molecular Therapy|2024

Cited by 83

IL7 increases targeted lipid nanoparticle–mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation

Caitlin M. Tilsed, Hamideh Parhiz, Barzan A. Sadiq et al.|Proceedings of the National Academy of Sciences|2024

Cited by 49

Indexing the rest of 62 publications…